Skip to main content
OpenTrials
Completed

NCT Number: NCT03128125

Study of Gesture and Executive Functions in Children With High Intellectual Potential

The main objective of this study is to determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

High Intellectual Potential Children

Age range

6 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital

Brest, 29200, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All participants :

  • Informed consent of the child and both parents obtained
  • Affiliated to Social Security
  • Participants must be between 6 and 16 years of age.

Child with high intellectual potential :

  • Score ≥ 130 on an intellectual efficiency scale administered by a psychologist

Control child :

  • They will have to be intellectually efficient in the standard. To ensure this, the two sub-tests of the Intellectual Efficiency Scale (WISC-V) most closely correlated with intelligence (Vocabulary and Matrices) will be administered to them. Thus, the child must meet one of the following criteria in order to be included:
  • Have two standard notes between -1 and +1 DS (between 7 and 13);
  • Have one of its two notes between -1 and + 1DS (between 7 and 13) and the other between -2DS and <+ 2DS (between 5 and 15).

Exclusion criteria

All participants :

  • Neurological history (epilepsy, cranial trauma, prematurity ...)
  • Psychiatric history (Autistic Spectrum Disorder ...),
  • Known genetic disease,
  • Motor deficiency (eg hemiplegia),
  • Elementary sensory disorder (auditory and visual) or insufficient command of French, limiting the understanding and participation in the study likely to impact the results to the protocol.
  • Gnosic visual or linguistic deficiency.
  • Sensory disorder
  • Psychotropic Intake

Control child :

  • High intellectual potential
  • Known or suspected learning disability (no dyslexia-dysorthography, dysphasia, dyspraxia, dyscalculia).

Treatment and study plan

clinical examination in neurology

Other

This examination is based on the movement of the child in a standing position (forward and backward on a straight line, jumping on a foot ...), seated (visual continuation ...) and elongated (tone, patellar and achillian reflexes, superficial sensitivity ...) . This makes it possible to evaluate all the neurological systems.

Neuropsychological examination

Other

This examination is based on the use of standardized psychometric tools and validated with children, usually used in clinical practice.

anamnestic elements

Other

Several elements will be collected during the clinical interview to inform the history of the child's development, such as neonatal data (term of pregnancy, APGAR score ...), age of appearance of the first words , seating, walking, possible care, level of education ans level of education of the parents.

Primary outcomes

  1. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children with WISC-V scale (Wechsler).

  2. Neurological assessments

    Time frame: 1 day

    Dysfunction (yes/no) for children with high intellectual potential compared to control children.

  3. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With Purdue Pegboard test.

  4. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With subtest Fluence Verbale (NEPSY-II)

  5. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With subtest of motricity (NEPSY-II)

  6. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With Rey test

  7. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With writing test (BHK)

  8. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With New card sorting test

  9. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With comportemental scale (BRIEF)

  10. Neuropsychological assessment

    Time frame: 1 day

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With M-ABC-II questionary

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: MOHPI

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Apr 25, 2017
Registry last updated
Oct 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.